TP53 Status, Patient Sex, and the Immune Response as Determinants of Lung Cancer Patient Survival

TP53 Status, Patient Sex, and the Immune Response as Determinants of Lung Cancer Patient Survival

Lung cancer poses the greatest cancer-related death risk and males have poorer outcomes than females, for unknown reasons. Patient sex is not a biological variable considered in lung cancer standard of care. Correlating patient genetics with outcomes is predicted to open avenues for improved managem...

Full description

Bibliographic Details
Main Authors: Donald Freudenstein, Cassandra Litchfield, Franco Caramia, Gavin Wright, Benjamin J. Solomon, David Ball, Simon P. Keam, Paul Neeson, Ygal Haupt, Sue Haupt
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Cancers
Subjects:
<i>TP53</i>
lung cancer
sex disparity
LUAD
LUSC
immune signatures
Online Access:https://www.mdpi.com/2072-6694/12/6/1535

Internet

https://www.mdpi.com/2072-6694/12/6/1535

Similar Items